A single nucleotide polymorphism on the promoter of eotaxin1 associates with its mRNA expression and asthma phenotypes

Journal of Immunology

Volumn 174, Issue 3, 2005, Pages 1525-1531

  Hun, Soo Chang ^a   Jung, Sun Kim ^a   June, Hyuk Lee ^b   Jung, Il Cho ^a   Tai, Youn Rhim ^b   Uh, Soo Taek ^b   Byung, Lae Park ^c   Il, Yup Chung ^a   Park, Choon Sik ^b   Hyoung, Doo Shin ^c  

^a Hanyang University   (South Korea)

^b Soonchunhyang University   (South Korea)

^c SNP Genetics Inc   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

EOTAXIN; IMMUNOGLOBULIN E; MESSENGER RNA; METHACHOLINE; TUMOR NECROSIS FACTOR;

ADULT; AGED; ALLELE; AMINO ACID SUBSTITUTION; ARTICLE; ASTHMA; BINDING SITE; BLOOD CELL COUNT; BLOOD LEVEL; CONTROLLED STUDY; DNA PROTEIN COMPLEX; EOSINOPHIL; FEMALE; FORCED EXPIRATORY VOLUME; GENE EXPRESSION; GENETIC ASSOCIATION; GENETIC TRANSCRIPTION; HAPLOTYPE; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; RNA TRANSLATION; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 19944432165     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.174.3.1525     Document Type: Article

References (40)

1. Kitaura, M., T. Nakajima, T. Imai, S. Harada, C. Combadiere, H. L. Tiffany, P. M. Murphy, and O. Yoshie. 1996. Molecular cloning of human eotaxin, an eosinophil-selective CC chemokine, and identification of a specific eosinophil eotaxin receptor, CC chemokine receptor 3. J. Biol. Chem. 271:7725.
2. Ponath, P. D., S. Qin, T. W. Post, J. Wang, L. Wu, N. P. Gerard, W. Newman, C. Gerard, and C. R. Mackay. 1996. Molecular cloning and characterization of a human eotaxin receptor expressed selectively on eosinophils. J. Exp. Med. 183:2437.
3. Gerber, B. O., M. P. Zanni, M. Uguccioni, M. Loetscher, C. R. Mackay, W. J. Pichler, N. Yawalkar, M. Baggiolini, and B. Moser. 1997. Functional expression of the eotaxin receptor CCR3 in T lymphocytes co-localizing with eosinophils. Curr. Biol. 7:836.
4. Sallusto, F., C. R. Mackay, and A. Lanzavecchia. 1997. Selective expression of the eotaxin receptor CCR3 by human T helper 2 cells. Science 277:2005.
5. Uguccioni, M., C. R. Mackay, B. Ochensberger, P. Loetscher, S. Rhis, G. J. LaRosa, P. Rao, P. D. Ponath, M. Baggiolini, and C. A. Dahinden. 1997. High expression of the chemokine receptor CCR3 in human blood basophils. Role in activation by eotaxin, MCP-4, and other chemokines. J. Clin. Invest. 100:1137.
6. de Paulis, A., F. Annunziato, L. DiGioia, S. Romagnani, M. Carfora, C. Beltrame, G. Marone, and P. Romagnani. 2001. Expression of the chemokine receptor CCR3 on human mast cells. Int. Arch. Allergy Immunol. 124:146.
7. Ochi, H., W. M. Hirani, Q. Yuan, D. S. Friend, K. F. Austen, and J. A. Boyce. 1999. T helper cell type 2 cytokine-mediated comitogenic responses and CCR3 expression during differentiation of human mast cells in vitro. J. Exp. Med. 190:267.
8. Ying, S., D. S. Robinson, Q. Meng, J. Rottman, R. Kennedy, D. J. Ringler, C. R. Mackay, B. L. Daugherty, M. S. Springer, S. R. Durham, et al. 1997. Enhanced expression of eotaxin and CCR3 mRNA and protein in atopic asthma. Association with airway hyperresponsiveness and predominant co-localization of eotaxin mRNA to bronchial epithelial and endothelial cells. Eur. J. Immunol. 27:3507.
9. Mattoli, S., M. A. Stacey, G. Sun, A. Bellini, and M. Marini. 1997. Eotaxin expression and eosinophitic inflammation in asthma. Biochem. Biophys. Res. Commun. 236:299.
10. Nakamura, H., S. T. Weiss, E. Israel, A. D. Luster, J. M. Drazen, and C. M. Lilly. 1999. Eotaxin and impaired lung function in asthma. Am. J. Respir. Crit. Care Med. 160:1952.
11. Park, S. W., D. J. Kim, H. S. Chang, S. J. Park, Y. M. Lee, J. S. Park, I. Y. Chung, J. H. Lee, and C. S. Park. 2003. Association of interleukin-5 and eotaxin with acute exacerbation of asthma. Int. Arch. Allergy Immunol. 131:283.
12. Mould, A. W., K. I. Matthaei, I. G. Young, and P. S. Foster. 1997. Relationship between interleukin-5 and eotaxin in regulating blood and tissue eosinophilia in mice. J. Clin. Invest. 99:1064.
13. van Rensen, E. L., R. G. Stirling, J. Scheerens, K. Staples, P. J. Sterk, P. J. Barnes, and K. F. Chung. 2001. Evidence for systemic rather than pulmonary effects of interleukin-5 administration in asthma. Thorax 56:935.
14. Wang, J., K. Palmer, J. Lotvall, S. Milan, X. F. Lei, K. I. Matthaei, J. Gauldie, M. D. Inman, M. Jordana, and Z. Xing. 1998. Circulating, but not local lung, IL-5 is required for the development of antigen-induced airways eosinophilia. J. Clin. Invest. 102:1132.
15. Hein, H., C. Schluter, R. Kulke, E. Christophers, J. M. Schroder, and J. Bartels. 1997. Genomic organization, sequence, and transcriptional regulation of the human eotaxin gene. Biochem. Biophys. Res. Commun. 237:537.
16. Dizier, M. H., C. Besse-Schmittler, M. Guilloud-Bataille, I. Annesi-Maesano, M. Boussaha, J. Bousquet, D. Charpin, A. Degioanni, F. Gormand, A. Grimfeld, et al. 2000. Genome screen for asthma and related phenotypes in the French EGEA study. Am. J. Respir. Crit. Care Med. 162:1812.
17. Shin, H. D., L. H. Kim, B. L. Park, J. H. Jung, J. Y. Kim, I. Y. Chung, J. S. Kim, J. H. Lee, S. H. Chung, Y. H. Kim, et al. 2003. Association of Eotaxin gene family with asthma and serum total IgE. Hum. Mol. Genet. 12:1279.
18. Miyamasu, M., T. Sekiya, K. Ohta, C. Ra, O. Yoshie, K. Yamamoto, N. Tsuchiya, K. Tokunaga, and K. Hirai. 2001. Variations in the human CC chemokine eotaxin gene. Genes Immun. 2:461.
19. Nakamura, H., A. D. Luster, T. Nakamura, K. H. In, L. A. Sonna, A. Deykin, E. Israel, J. M. Drazen, and C. M. Lilly. 2001. Variant eotaxin: its effects on the asthma phenotype. J. Allergy Clin. Immunol. 108:946.
20. Tsunemi, Y., H. Saeki, K. Nakamura, T. Sekiya, K. Hirai, H. Fujita, N. Asano, Y. Tanida, T. Kakinuma, M. Wakugawa, et al. 2002. Eotaxin gene single nucleotide polymorphisms in the promoter and exon regions are not associated with susceptibility to atopic dermatitis, but two of them in the promoter region are associated with serum IgE levels in patients with atopic dermatitis. J. Dermatol. Sci. 29:222.
21. National Institutes of Health. 2002. Global strategy for asthma management and prevention, NHLBI/WHO Workshop Report. National Heart, Lung, and Blood Institute. National Institutes of Health, Bethesda, pp. 1-7.
22. No authors listed. 1987. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma: this official statement of the American Thoracic Society was adopted by the ATS Board of Directors, November 1986. Am. Rev. Respir. Dis. 136:225.
23. Chai, H., R. S. Farr, L. A. Froehlich, D. A. Mathison, J. A. McLean, R. R. Rosenthal, A. L. Sheffer, S. L. Spector, and R. G. Townley. 1975. Standardization of bronchial inhalation challenge procedures. J. Allergy Clin. Immunol. 56:323.
24. Ferris, B. G. 1978. Epidemiology Standardization Project II: recommended respiratory disease questionnaires for use with adults and children in epidemiological research. Am. Rev. Respir. Dis. 118:10.
25. Park, C. S., Y. Y. Kim, and S. Y. Kang. 1984. Collection between RAST and skin test for inhalant offending allergens. J. Kor. Soc. Allergol. 983:1.
26. Matsukura, S., C. Stellato, J. R. Plitt, C. Bickel, K. Miura, S. N. Georas, V. Casolaro, and R. P. Schleimer. 1999. Activation of eotaxin gene transcription by NF-κB and STAT6 in human airway epithelial cells. J. Immunol. 163:6876.
27. Chung, I. Y., Y. H. Kim, M. K. Choi, Y. J. Noh, C. S. Park, Y. K. Do, D. Y. Lee, Y. S. Lee, H. S. Chang, and K. S. Kim. 2004. Eotaxin and monocyte chemotactic protein-3 use different modes of action. Biochem. Biophys. Res. Commun. 314:646.
28. Pease, J. E., J. Wang, P. D. Ponath, and P. M. Murphy. 1998. The N-terminal extracellular segments of the chemokine receptors CCR1 and CCR3 are determinants for MIP-1α and eotaxin binding, respectively, but a second domain is essential for efficient receptor activation. J. Biol. Chem. 273:19972.
29. Stephens, M., N. J. Smith, and P. Donnelly. 2001. A new statistical method for haplotype reconstruction from population data. Am. J. Hum. Genet. 68:978.
30. Jinquan, T., H. H. Jacobi, C. Jing, A. Millner, E. Sten, L. Hviid, L. Anting, L. P. Ryder, C. Glue, P. S. Skov, et al. 2003. CCR3 expression induced by IL-2 and IL-4 functioning as a death receptor for B cells. J. Immunol. 171:1722.
31. Garcia-Zepeda, E. A., M. E. Rothenberg, S. Weremowicz, M. N. Sarafi, C. C. Morton, and A. D. Luster. 1997. Genomic organization, complete sequence, and chromosomal location of the gene for human eotaxin (SCYA11), an eosinophil-specific CC chemokine. Genomics 41:471.
32. Bartels, J., C. Schluter, E. Richter, N. Noso, R. Kulke, E. Christophers, and J. M. Schroder. 1996. Human dermal fibroblasts express eotaxin: molecular cloning, mRNA expression, and identification of eotaxin sequence variants. Biochem. Biophys. Res. Commun. 225:1045.
33. Hemmerich, S., C. Paavola, A. Bloom, S. Bhakta, R. Freedman, D. Grunberger, J. Krstenansky, S. Lee, D. McCarley, M. Mulkins, et al. 1999. Identification of residues in the monocyte chemotactic protein-1 that contact the MCP-1 receptor, CCR2. Biochemistry 38:13013.
34. Nibbs, R. J., T. W. Salcedo, J. D. Campbell, X. T. Yao, Y. Li, B. Nardelli, H. S. Olsen, T. S. Morris, A. E. Proudfoot, V. P. Patel, and G. J. Graham. 2000. C-C chemokine receptor 3 antagonism by the β-chemokine macrophage inflammatory protein 4, a property strongly enhanced by an amino-terminal alanine-methionine swap. J. Immunol. 164:1488.
35. Fikes, J. D., G. A. Barkocy-Gallagher, D. G. Klapper, and P. J. J. Bassford. 1990. Maturation of Escherichia coli maltose-binding protein by signal peptidase I in vivo: sequence requirements for efficient processing and demonstration of an alternate cleavage site. J. Biol. Chem. 265:3417.
36. Rittig, S., G. L. Robertson, C. Siggaard, L. Kovacs, N. Gregersen, J. Nyborg, and E. B. Pedersen. 1996. Identification of 13 new mutations in the vasopressin-neurophysin II gene in 17 kindreds with familial autosomal dominant neurohypophyseal diabetes insipidus. Am. J. Hum. Genet. 58:107.
37. Silverman, E. K., and L. J. Palmer. 2000. Case-control association studies for the genetics of complex respiratory diseases. Am. J. Respir. Cell Mol. Biol. 22:645.
38. Han, S. J., J. H. Kim, Y. J. Noh, H. S. Chang, C. S. Kim, K. S. Kim, S. Y. Ki, C. S. Park, and I. Y. Chung. 1999. Interleukin (IL)-5 downregulates tumor necrosis factor (TNF)-induced eotaxin messenger RNA (mRNA) expression in eosinophils: induction of eotaxin mRNA by TNF and IL-5 in eosinophils. Am. J. Respir. Cell Mol. Biol. 21:303.
39. Hoeck, J., and M. Woisetschlager. 2001. STAT6 mediates eotaxin-1 expression in IL-4 or TNF-α-induced fibroblasts. J. Immunol. 166:4507.
40. Matsukura, S., F. Kokubu, H. Kuga, M. Kawaguchi, K. Ieki, M. Odaka, S. Suzuki, S. Watanabe, H. Takeuchi, M. Adachi, et al. 2003. Differential regulation of eotaxin expression by IFN-γ in airway epithelial cells. J. Allergy Clin. Immunol. 111:1337.